a public good project by the
Synthesis
Company
of California

© 2026

Ningjing Lin | doi.page

0 works0 citations0 h-index

Ningjing Lin

Guangxi Medical University(CN)Peking University(CN)Peking University Cancer Hospital(CN)Ministry of Education(ET)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Viral-associated cancers and disorders, CAR-T cell therapy research, Epigenetics and DNA Methylation, Chronic Lymphocytic Leukemia Research

Most-Cited Works

→ Glioblastoma multiforme: a review of where we have been and where we are going(2009)548 cited
→ A safe and potent anti-CD19 CAR T cell therapy(2019)439 cited
→ Glioblastoma multiforme: a review of therapeutic targets(2009)170 cited
→ Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma(2019)163 cited
→ Glioblastoma Multiforme Oncogenomics and Signaling Pathways(2009)143 cited
→ L-Asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type(2008)114 cited

→ Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin(2015)

95 cited

→ A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type(2013)69 cited

→ Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades(2020)66 cited

→ Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome(2016)66 cited